Literature DB >> 32996236

Enhanced in vitro antimicrobial activity of amphotericin B with berberine against dual-species biofilms of Candida albicans and Staphylococcus aureus.

S Gao1, S Zhang1,2, S Zhang1,2.   

Abstract

AIMS: Multi-species biofilms formed by fungi and bacteria are clinically common and confer the commensal micro-organisms with protection against antimicrobial therapies. Previously, the plant alkaloid berberine was reported to show antimicrobial efficacy to eliminate bacterial and fungal biofilms. In this study, the combination of berberine and amphotericin B, an antifungal agent, was evaluated against dual-species Candida albicans/Staphylococcus aureus biofilms. METHODS AND
RESULTS: Combinatorial treatment by berberine and amphotericin B significantly reduced the biomass and viability of residing species in biofilms. Moreover, morphological examination revealed hyphal filamentation of C. albicans and coadhesion between C. albicans/S. aureus were considerably impaired by the treatment. These effects coincided with the reduced expression of cell surface components and quorum-sensing-related genes in both C. albicans and S. aureus. Additionally, in C. albicans, the core transcription factors for controlling biofilm formation together with a crucial component of dual-species biofilms were also downregulated.
CONCLUSIONS: These results demonstrated synergistic effects of berberine and amphotericin B against C. albicans/S. aureus dual-species biofilms. SIGNIFICANCE AND IMPACT OF THE STUDY: This study confirms the potential of berberine and amphotericin B for treating the C. albicans/S. aureus biofilms related infections and reveals molecular basis for the efficacy of combinatorial treatment.
© 2020 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Candida albicanszzm321990; zzm321990Staphylococcus aureuszzm321990; amphotericin B; berberine; dual-species biofilms

Mesh:

Substances:

Year:  2020        PMID: 32996236     DOI: 10.1111/jam.14872

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

Review 1.  In it together: Candida-bacterial oral biofilms and therapeutic strategies.

Authors:  Geelsu Hwang
Journal:  Environ Microbiol Rep       Date:  2022-02-26       Impact factor: 3.541

2.  Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials.

Authors:  Noor Akbar; Muhammad Kawish; Naveed Ahmed Khan; Muhammad Raza Shah; Ahmad M Alharbi; Hasan Alfahemi; Ruqaiyyah Siddiqui
Journal:  Antibiotics (Basel)       Date:  2022-05-20

Review 3.  Recent Advances and Opportunities in the Study of Candida albicans Polymicrobial Biofilms.

Authors:  Carolina H Pohl
Journal:  Front Cell Infect Microbiol       Date:  2022-02-18       Impact factor: 5.293

4.  In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients.

Authors:  Shuai Xia; Liyan Ma; Guoxing Wang; Jie Yang; Meiying Zhang; Xuechen Wang; Jianrong Su; Miaorong Xie
Journal:  Infect Drug Resist       Date:  2022-04-19       Impact factor: 4.177

Review 5.  Herbal Products and Their Active Constituents Used Alone and in Combination with Antifungal Drugs against Drug-Resistant Candida sp.

Authors:  Anna Herman; Andrzej Przemysław Herman
Journal:  Antibiotics (Basel)       Date:  2021-05-31

Review 6.  Bioactivity of Chitosan-Based Particles Loaded with Plant-Derived Extracts for Biomedical Applications: Emphasis on Antimicrobial Fiber-Based Systems.

Authors:  Joana C Antunes; Joana M Domingues; Catarina S Miranda; A Francisca G Silva; Natália C Homem; M Teresa P Amorim; Helena P Felgueiras
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.